Profusa, Inc. Common Stock (PFSA) - Total Assets
Based on the latest financial reports, Profusa, Inc. Common Stock (PFSA) holds total assets worth $4.25 Million USD as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See Profusa, Inc. Common Stock net assets for net asset value and shareholders' equity analysis.
Profusa, Inc. Common Stock - Total Assets Trend (2021–2024)
This chart illustrates how Profusa, Inc. Common Stock's total assets have evolved over time, based on quarterly financial data.
Profusa, Inc. Common Stock - Asset Composition Analysis
Current Asset Composition (December 2024)
Profusa, Inc. Common Stock's total assets of $4.25 Million consist of 8.5% current assets and 91.5% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 6.2% |
| Accounts Receivable | $0.00 | 0.0% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2021–2024)
This chart illustrates how Profusa, Inc. Common Stock's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see PFSA market cap overview.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Profusa, Inc. Common Stock's current assets represent 8.5% of total assets in 2024, an increase from 8.4% in 2021.
- Cash Position: Cash and equivalents constituted 6.2% of total assets in 2024, down from 7.5% in 2021.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2021.
- Asset Diversification: The largest asset category is goodwill at 0.0% of total assets.
Profusa, Inc. Common Stock Competitors by Total Assets
Key competitors of Profusa, Inc. Common Stock based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
INKON Life Technology Co Ltd
SHE:300143
|
China | CN¥4.15 Billion |
|
CareRay Digital Medical Technology Co Ltd
SHG:688607
|
China | CN¥988.48 Million |
|
Senseonics Holdings, Inc. Common Stock
NYSE MKT:SENS
|
USA | $139.92 Million |
|
Universus Photo Imagings Limited
NSE:UNIVPHOTO
|
India | Rs8.57 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
|
Aligned Genetics Inc
KQ:238120
|
Korea | ₩45.11 Billion |
|
Heramed Ltd
AU:HMD
|
Australia | AU$1.04 Million |
|
Acarix A/S
ST:ACARIX
|
Sweden | Skr48.33 Million |
Profusa, Inc. Common Stock - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.18 | 0.13 | 0.32 |
| Quick Ratio | 0.18 | 0.13 | 0.32 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-19.34 Million | $-4.48 Million | $-3.35 Million |
Profusa, Inc. Common Stock - Advanced Valuation Insights
This section examines the relationship between Profusa, Inc. Common Stock's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 2.55 |
| Asset Growth Rate (YoY) | 62.3% |
| Total Assets | $3.07 Million |
| Market Capitalization | $7.85 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values Profusa, Inc. Common Stock's assets at a significant premium (2.55x), suggesting investors see substantial growth potential or unique competitive advantages.
Rapid Asset Growth: Profusa, Inc. Common Stock's assets grew by 62.3% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Profusa, Inc. Common Stock (2021–2024)
The table below shows the annual total assets of Profusa, Inc. Common Stock from 2021 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $3.07 Million | +62.33% |
| 2023-12-31 | $1.89 Million | +83.61% |
| 2022-12-31 | $1.03 Million | -90.93% |
| 2021-12-31 | $11.36 Million | -- |
About Profusa, Inc. Common Stock
Profusa, Inc. develops bioengineered sensors for body to detect and continuously transmit clinical-grade data for personal and medical use in the United States. It offers the Lumee Oxygen Platform to monitor compromised tissue for peripheral artery disease, chronic wounds, and reconstructive surgery. The company researches and develops the Lumee Glucose Platform which is designed to monitor gluco… Read more